Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)
Collecte de données
Maladie de la valve aortique+43
+ Laminopathies
+ Maladies génito-urinaires
Résumé
Date de début de l'étude : 10 mai 1992
Date à laquelle le premier participant a commencé l'étude.The principal mission of the NIH is the conduct of research that elucidates biological mechanisms, pathogenesis, and treatment of disease. Patients with known or suspected cardiovascular diseases are referred to NHLBI cardiologists for consideration of participation in clinical research protocols. However, eligibility for participation is often uncertain from referral information or even after an outpatient evaluation. The purpose of this protocol is to permit inpatient evaluation of patients for whom participation in clinical research protocols is under consideration in order to determine protocol eligibility by means of conventional laboratory and cardiovascular testing.
Protocole
Cette section fournit des détails sur le plan de l'étude, y compris la manière dont l'étude est conçue et ce qu'elle évalue.Éligibilité
Les chercheurs recherchent des patients correspondant à une certaine description appelée critères d'éligibilité : état de santé général ou traitements antérieurs du patient.Tout sexe
Le sexe biologique des participants éligibles à s'inscrire.Volontaires sains non autorisés
Indique si les individus en bonne santé et ne présentant pas la condition étudiée peuvent participer.Conditions
Pathologie
Critères
INCLUSION CRITERIA: The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol: Coronary artery disease with angina or inducible myocardial ischemia as determined by noninvasive testing. Cardiomyopathies including congestive phenotypes. Peripheral artery disease with intermittent claudication or limb-threatening ischemia. Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy. Upper extremity peripheral artery disease. Diabetes with heart failure. Pulmonary hypertension. EXCLUSION CRITERIA: Pregnancy, for those patients who require catheterization-based diagnostics. Inability to provide informed consent.
Centres d'étude
Ce sont les hôpitaux, cliniques ou centres de recherche où l'essai est conduit. Vous pouvez trouver le site le plus proche de vous ainsi que son statut.Cette étude comporte 2 sites
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, United States